Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy

Clinical trial NCT07090278 · COMPLETED

Trial details

NCT number: NCT07090278
Sponsor: Shusheng Li
Status: COMPLETED
Study type: OBSERVATIONAL

Sepsis-Associated Encephalopathy

Start date: 2019-01-01
Primary completion: 2024-10-31
Enrollment: 2734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.